Dr Ivana Stolfa
Post-Doctoral Research Associate
Ivana studied Pharmacy before pursuing a PhD in Pharmaceutical Science at King’s College London, where she developed in vitro, in vivo, and in silico tools for the biopharmaceutical assessment of nanomedicine platforms.
Her research focused on developing albumin nanoparticles encapsulated in microparticles as a novel drug delivery system targeting the lungs. After completing her doctoral studies, she worked as a Senior Scientist at Pfizer. In September 2024, she joined Vax Hub, where she is involved in the miniaturization and scaling of vaccine production.